PhD Tina Fink
no.: 35277

researcher – active in research organisation

tina.fink

at sign

ki.si

Research activity

Code	Science	Field	Subfield
1.05.00	Natural sciences and mathematics	Biochemistry and molecular biology

Bibliography Representative bibliographic units | Personal| COBISS+

source: COBISS

source: SICRIS

Evaluation (rules)

Evaluation of bibliographic research performance indicators according to ARIS methodology

source: COBISS

source: ARIS

Points

184.18

A''

59.84

A'

137.56

A1/2

153.71

CI10

165

CImax

110

h10

5

A1

0.72

A3

0.72

Data for the last 5 years (citations for the last 10 years) on September 12, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)

Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )

Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases

source: WoS

source: Scopus

source: COBISS

Database	Linked records	Citations	Pure citations	Average pure citations
WoS	5	189	162	32.4
Scopus	6	187	156	26

Education

source: ARIS

Level of education	Professional title	Study subject	Faculty	Year
Doctor's degree	Ph. D.			2019

Doctoral dissertations and other final papers Show

source: COBISS

Employments

source: ARIS

Type of employment	Research org.	Research group	Date of employment	Position	Role	Title
Full time employment (100%, RD:100%)	National Institute of Chemistry	Department of Synthetic Biology and Immunology	9/1/2014	Research associate	Researcher
Full time employment (2.5%, RD:2.5%)	EN-FIST CENTRE OF EXCELLENCE	RS EN-FIST (Slovene)	9/1/2024	Research associate	Researcher

Research projects Legend

source: ARIS

no.	Code	Title	Period	Head	No. of publications
1.	J1-4406	CC-Trigger: toehold mediated protein coiled-coil displacement to introduce kinetic control of protein assemblies and advanced multi-state devices.	2022 - 2024	PhD Ajasja Ljubetič	1,576
2.	J7-4537	GENOTYPE-PHENOTYPE CORRELATION STUDY OF CTNNB1 SYNDROME AND INVESTIGATION OF NOVEL APPROACHES TO ITS TREATMENT	2022 - 2024	PhD Damjan Osredkar	2,036
3.	J7-4640	Innovative CAR T cell cancer immunotherapy (CARRS)	2022 - 2024	PhD Roman Jerala	4,249
4.	J7-4493	Microfluidic mechanoporation for cell therapy	2022 - 2024	PhD Jure Derganc	1,458
5.	Z4-2657	Design of phosphorylation-regulated signaling pathways in mammalian cells	2020 - 2022	PhD Tina Fink	27
6.	V4-2038	DNA vaccine and peptide inhibitors against SARS-CoV-2	2020	PhD Roman Jerala	8,348
7.	J3-1752	APOPTOSIS TARGETING OF LEUKEMIC CELLS IN CHRONIC MYELOID LEUKEMIA USING Cas9 – TargetCML9	2019 - 2020	PhD Matjaž Sever	2,659
8.	J3-9268	Cancer immunotherapy modulation by ultrasound	2018 - 2020	PhD Mojca Benčina	1,727
9.	J1-9173	Design of a fast signaling and logic processing pathway based on orthogonal proteases	2018 - 2020	PhD Roman Jerala	1,617
10.	J3-9257	Molecular mechanism of endogenous TLR4 agonist formation and its role in chronic inflammatory diseases	2018 - 2020	PhD Mateja Manček Keber	1,611
11.	N4-0080	Optimizacija sinteznobioloških genskih vezij in reprogramiranja celic s pomočjo mikrofluidike (Slovene)	2018 - 2020	PhD Roman Jerala	1,497
12.	J3-8211	Development of anti-inflammatory regulatory T cells (Treg) for therapy of autoimmune diabetes using designed transcriptional factors and CRISPR/Cas9 system	2017 - 2019	PhD Simon Horvat	4,196
13.	J3-6784	The molecular mechanism of single stranded DNA signaling via intracellular Toll-like receptor 9	2017	PhD Mojca Benčina	2,263

ARIS research and infrastructure programmes Legend

source: ARIS

no.	Code	Title	Period	Head	No. of publications
1.	P4-0176	Synthetic biology and immunology	2022 - 2024	PhD Roman Jerala	2,369
2.	P4-0176	Molecular Biotechnology: from the Dynamics of Biological Systems to Applications	2015 - 2021	PhD Roman Jerala	3,014